D-0766-2021 Class II Terminated
FDA drug recall D-0766-2021 was initiated by SigmaPharm Laboratories LLC on Aug 13, 2021 and is designated Class II. Reason for recall: Failed Impurities Specifications: Out of Specification impurity results obtained during routine testing. The recall status is terminated (terminated Sep 26, 2022). Affected quantity: 1,993 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 1, 2021
- Initiation Date
- Aug 13, 2021
- Termination Date
- Sep 26, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,993 bottles
Product description
Sodium Phenylbutyrate POWDER, 250 grams bottle, Rx Only, Sigmapharm Laboratories, LLC Bensalem, PA 19020 NDC 42794-086-14 UPC Code# 3 42794 086 14 4
Reason for recall
Failed Impurities Specifications: Out of Specification impurity results obtained during routine testing.
Distribution pattern
Disttibuted Nationwide in the USA.
Code information
Lot Numbers: 1813001, 1813101, 1813201, EXP. May 2023; 1822601, 1822701, EXP Nov 2023; 1905701, 1905801, 1906501, 1906601, 1906701, EXP May 2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0766-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026